tirzepatide death burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life. Read: Link in bio #health #medicine #drugs Stopping GLP-1 drugs can quickly

Reduced Risk of Major Cardiovascular Events Clinical trials, such as the SUSTAIN-6 and PIONEER-6 studies, have demonstrated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular-related death

Er is meer onderzoek nodig om dit resultaat te bevestigen

However, it has been shown that GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing UPR and promoting macroautophagy (144)

Step 4: follow the standard tirzepatide titration schedule The standard tirzepatide titration increases the dose every four weeks: Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Weeks 17-20: 12.5mg weekly Weeks 21+: 15mg weekly (maximum dose) Not everyone needs to reach 15mg

Therefore, an initial screening with a medical professional is important to ensure safe administration